Spotlight on nicotine analogues in the US triggers regulatory and health questions

The tobacco industry, public health groups, and the World Health Organization (WHO) have all recently drawn attention to nicotine analogues – compounds chemically similar to but distinct from nicotine. What are these compounds and why the attention?

Unlock access

Want the full analysis? Let's talk

We share insights with professionals we’re in contact with. Let us know a bit about your interest.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Name*

Want the full analysis? Let's talk

We share insights with professionals we’re in contact with. Let us know a bit about your interest.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Name*